Genetic medicine gets real

被引：13

作者：

Abbott, A

机构：

来源：

NATURE | 2001年 / 411卷 / 6836期

关键词：

D O I：

10.1038/35078232

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Gene therapists used to talk about permanently fixing 'broken' genes. But the emphasis has now shifted to treating conditions such as coronary disease and cancer using transient gene expression. Alison Abbott reports.

引用

页码：410 / 412

页数：3

共 11 条

[1] RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY [J].

FYFE, G ;

FISHER, RI ;

ROSENBERG, SA ;

SZNOL, M ;

PARKINSON, DR ;

LOUIE, AC .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :688-696

[2] Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart [J].

Mack, CA ;

Patel, SR ;

Schwarz, EA ;

Zanzonico, P ;

Hahn, RT ;

Ilercil, A ;

Devereux, RB ;

Goldsmith, SJ ;

Christian, TF ;

Sanborn, TA ;

Kovesdi, I ;

Hackett, N ;

Isom, OW ;

Crystal, RG ;

Rosengart, TK .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (01) :168-176

[3] Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen [J].

Marshall, JL ;

Hawkins, MJ ;

Tsang, KY ;

Richmond, E ;

Pedicano, JE ;

Zhu, MZ ;

Schlom, J .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :332-337

[4] Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses [J].

Marshall, JL ;

Hoyer, RJ ;

Toomey, MA ;

Faraguna, K ;

Chang, P ;

Richmond, E ;

Pedicano, JE ;

Gehan, E ;

Peck, RA ;

Arlen, P ;

Tsang, KY ;

Schlom, J .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :3964-3973

[5] Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status:: a clinical phase I study [J].

Möller, P ;

Sun, Y ;

Dorbic, T ;

Alijagic, S ;

Makki, A ;

Jurgovsky, K ;

Schroff, M ;

Henz, BM ;

Wittig, B ;

Schadendorf, D .

BRITISH JOURNAL OF CANCER, 1998, 77 (11) :1907-1916

[6] Progress in human tumour immunology and immunotherapy [J].

Rosenberg, SA .

NATURE, 2001, 411 (6835) :380-384

[7] Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens [J].

Rosenberg, SA ;

Zhai, YF ;

Yang, JC ;

Schwartzentruber, DJ ;

Hwu, P ;

Marincola, F ;

Topalian, SL ;

Restifo, NP ;

Seipp, CA ;

Einhorn, JH ;

Roberts, B ;

White, DE .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (24) :1894-1900

[8] Angiogenesis gene therapy - Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease [J].

Rosengart, TK ;

Lee, LY ;

Patel, SR ;

Sanborn, TA ;

Parikh, M ;

Bergman, GW ;

Hachamovitch, R ;

Szulc, M ;

Kligfield, PD ;

Okin, PM ;

Hahn, RT ;

Devereux, RB ;

Post, MR ;

Hackett, NR ;

Foster, T ;

Grasso, TM ;

Lesser, ML ;

Isom, OW ;

Crystal, RG .

CIRCULATION, 1999, 100 (05) :468-474

[9] Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog [J].

Sato, N ;

Leopold, PL ;

Crystal, RG .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (07) :855-864

[10] Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study [J].

Sun, Y ;

Jurgovsky, K ;

Moller, P ;

Alijagic, S ;

Dorbic, T ;

Georgieva, J ;

Wittig, B ;

Schadendorf, D .

GENE THERAPY, 1998, 5 (04) :481-490

← 1 2 →